Aspen Grove Capital’s Steris STE Stock Holding History

Aspen Grove Capital’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,394	Closed	-$257K	–	174
2022 Q4	$257K	Buy	+1,394	New	+$245K	0.12%	124

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aspen Grove Capital's STE Position: Q1 2023 in Review

Aspen Grove Capital sold out of Steris (STE) in Q1 2023, closing a stake of 1,394 shares — an estimated $257K sold.

Aspen Grove Capital first reported a position in STE in Q4 2022 and held it in 1 quarter. The position peaked at $257K in Q4 2022. 621 funds tracked by Wall St. Rank hold STE as of Q1 2023.

Aspen Grove Capital reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
Aspen Grove Capital sold 1,394 Steris shares in Q1 2023, an estimated $257K.
Aspen Grove Capital first reported a position in Steris in Q4 2022 and held it in 1 quarter.
Aspen Grove Capital's Steris position peaked at $257K in Q4 2022.
621 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Aspen Grove Capital's 13F filing for Q1 2023, filed 15 May 2023.